The Journal of Thoracic and Cardiovascular Surgery
Volume 138, Issue 4 , Pages 831-836 , October 2009

Impact of tumor length on long-term survival of pT1 esophageal adenocarcinoma

  • William D. Bolton, MD

      Affiliations

    • Department of Thoracic and Cardiovascular Surgery, The University of Texas M. D. Anderson Cancer Center, Houston, Tex
    • ,
  • Wayne L. Hofstetter, MD

      Affiliations

    • Department of Thoracic and Cardiovascular Surgery, The University of Texas M. D. Anderson Cancer Center, Houston, Tex
    • ,
  • Ashleigh M. Francis, BS

      Affiliations

    • Department of Thoracic and Cardiovascular Surgery, The University of Texas M. D. Anderson Cancer Center, Houston, Tex
    • ,
  • Arlene M. Correa, MD

      Affiliations

    • Department of Thoracic and Cardiovascular Surgery, The University of Texas M. D. Anderson Cancer Center, Houston, Tex
    • ,
  • Jaffer A. Ajani, MD

      Affiliations

    • Department of Gastrointestinal Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Tex
    • ,
  • Manoop S. Bhutani, MD

      Affiliations

    • Department of Diagnostic Radiology, The University of Texas M. D. Anderson Cancer Center, Houston, Tex
    • ,
  • Jeremy Erasmus, MD

      Affiliations

    • Department of Gastrointestinal Medicine and Nutrition, The University of Texas M. D. Anderson Cancer Center, Houston, Tex
    • ,
  • Ritsuko Komaki, MD

      Affiliations

    • Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Tex
    • ,
  • Dipen M. Maru, MD

      Affiliations

    • Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Tex
    • ,
  • Reza J. Mehran, MD

      Affiliations

    • Department of Thoracic and Cardiovascular Surgery, The University of Texas M. D. Anderson Cancer Center, Houston, Tex
    • ,
  • David C. Rice, MD

      Affiliations

    • Department of Thoracic and Cardiovascular Surgery, The University of Texas M. D. Anderson Cancer Center, Houston, Tex
    • ,
  • Jack A. Roth, MD

      Affiliations

    • Department of Thoracic and Cardiovascular Surgery, The University of Texas M. D. Anderson Cancer Center, Houston, Tex
    • ,
  • Ara A. Vaporciyan, MD

      Affiliations

    • Department of Thoracic and Cardiovascular Surgery, The University of Texas M. D. Anderson Cancer Center, Houston, Tex
    • ,
  • Garrett L. Walsh, MD

      Affiliations

    • Department of Thoracic and Cardiovascular Surgery, The University of Texas M. D. Anderson Cancer Center, Houston, Tex
    • ,
  • Stephen G. Swisher, MD

      Affiliations

    • Department of Thoracic and Cardiovascular Surgery, The University of Texas M. D. Anderson Cancer Center, Houston, Tex
    • Corresponding Author InformationAddress for reprints: Stephen G. Swisher, MD, The University of Texas M. D. Anderson Cancer Center, Department of Thoracic and Cardiovascular Surgery, 1515 Holcombe Blvd, Box 445, Houston, TX 77030.

Received 9 May 2008 ,Revised 16 January 2009 ,Accepted 2 February 2009.

References 

  1. AJCC cancer staging handbook/American Joint Committee on Cancer. 6th ed. Philadelphia: Lippincott–Raven; 2002;p. 3-8, 91-103
  2. Beahrs OH, Myers MH. American Joint Committee on Cancer. Manual for Staging of Cancer. 2nd ed. Philedelphia: JB Lippincott; 1983;
  3. Sobin LH, Hermanek P, Hutter RVP. TNM classification of malignant tumors: a comparison between the new (1987) and the old editions. Cancer. 1988;61:2310–2314
  4. Bollschweiler E, Baldus SE, Schroder W, Schneider PM, Holscher AH. Staging of esophageal carcinoma: length of tumor and number of involved regional lymph nodes—are these independent prognostic factors?. J Surg Oncol. 2006;94:355–363
  5. Griffiths EA, Brummell Z, Gorthi G, Prichard SA, Welch IM. Tumor length as a prognostic factor in esophageal malignancy: univariate and multivariate survival analyses. J Surg Oncol. 2006;93:258–267
  6. Eloubeidi MA, Desmond R, Arguedas MR, Reed CE, Wilcox CM. Prognostic factors for the survival of patients with esophageal carcinoma in the U.S. The importance of tumor length and lymph node status. Cancer. 2002;95:1434–1443
  7. Yendamuri S, Swisher SG, Correa AM, Hofstetter W, Ajani JA, Francis A, et al. Esophageal tumor length is independently associated with long-term survival. Cancer. 2009;115:508–516
  8. Rice TW, Blackstone EH, Adelstein DJ, Zuccaro G, Vargo JJ, Goldblum JR, et al. Role of clinically determined depth of tumor invasion in the treatment of esophageal carcinoma. J Thorac Cardiovasc Surg. 2003;125:1091–1101
  9. Rizk N, Venkatraman E, Park B, Flores R, Bains MS, Rusch V. The prognostic importance of the number of involved lymph nodes in esophageal cancer: implications for revisions of the American Joint Committee on Cancer staging system. J Thorac Cardiovasc Surg. 2006;132:1374–1381
  10. Tachibana M, Kinugasa S, Dhar DK, Kotoh T, Shibakita M, Ohno S, et al. Prognostic factors after extended esophagectomy for squamous cell carcinoma of the thoracic esophagus. J Surg Oncol. 1999;72:88–93
  11. Altorki NK, Lee PC, Liss Y, Meherally D, Korst RJ, Christos P, et al. Multifocal neoplasia and nodal metastases in T1 esophageal carcinoma: implications for endoscopic treatment. Ann Surg. 2008;247:434–439
  12. Gu Y, Swisher SG, Ajani JA, Correa AM, Hofstetter WL, Liao Z, et al. The number of lymph nodes with metastasis predicts survival in patients with esophageal or esophagogastric junction adenocarcimona who receive preoperative chemoradiation. Cancer. 2006;106:1017–1025
  13. Cen P, Hofstetter WL, Correa AM, Wu TT, Lee JH, Ross WA, et al. Lymphovascular invasion as a tool to further subclassify T1b esophageal adenocarcinoma. Cancer. 2008;112:1020–1027
  14. Liu L, Hofstetter WL, Rashid A, Swisher SG, Correa AM, Ajani JA, et al. Significance of the depth of tumor invasion and lymph node metastasis in superficially invasive (T1) esophageal adenocarcinoma. Am J Surg Pathol. 2005;29:1079–1085
  15. Hofstetter W, Correa AM, Bekele N, Ajani JA, Phan A, Komaki RR, et al. Proposed modification of nodal status in AJCC esophageal cancer staging system. Ann Thorac Surg. 2007;84:365–375

 This work was supported by the Homer Flower Gene Therapy Research Fund, the Charles Rogers Gene Therapy Fund, the Flora & Stuart Mason Lung Cancer Research Fund, the Charles B. Swank Memorial Fund for Esophageal Cancer Research, the George O. Sweeney Fund for Esophageal Cancer Research, the Phalan Thoracic Gene Therapy Fund, and the M. W. Elkins Endowed Fund for Thoracic Surgical Oncology.

PII: S0022-5223(09)00176-7

doi: 10.1016/j.jtcvs.2009.02.003

The Journal of Thoracic and Cardiovascular Surgery
Volume 138, Issue 4 , Pages 831-836 , October 2009

Article Tools

* Image Usage & Resolution